Mechanisms of Heart Failure: Developments in Cardiovascular Medicine, cartea 167
Editat de Pawan K. Singal, Ian M.C. Dixon, Robert E. Beamish, Naranjan S. Dhallaen Limba Engleză Paperback – 12 oct 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1419.94 lei 6-8 săpt. | |
Springer Us – 12 oct 2012 | 1419.94 lei 6-8 săpt. | |
Hardback (1) | 1427.07 lei 6-8 săpt. | |
Springer Us – 31 dec 1995 | 1427.07 lei 6-8 săpt. |
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.50 lei
- 5% Preț: 375.17 lei
- 5% Preț: 354.10 lei
- 5% Preț: 1419.03 lei
- 5% Preț: 376.43 lei
- 5% Preț: 1098.27 lei
- 5% Preț: 1438.38 lei
- 5% Preț: 376.78 lei
- 5% Preț: 368.37 lei
- 5% Preț: 380.25 lei
- 5% Preț: 2117.58 lei
- 5% Preț: 367.28 lei
- 5% Preț: 366.56 lei
- 5% Preț: 371.10 lei
- 5% Preț: 370.94 lei
- 5% Preț: 783.18 lei
- 5% Preț: 713.18 lei
- 5% Preț: 1098.27 lei
- 5% Preț: 375.49 lei
- 5% Preț: 373.47 lei
- 5% Preț: 723.93 lei
- 5% Preț: 1104.13 lei
- 5% Preț: 2117.20 lei
- 5% Preț: 716.09 lei
- 5% Preț: 372.03 lei
- 5% Preț: 722.33 lei
- 5% Preț: 660.07 lei
- 5% Preț: 375.34 lei
- 5% Preț: 1423.22 lei
- 5% Preț: 715.35 lei
- 5% Preț: 790.69 lei
- 5% Preț: 720.68 lei
- 5% Preț: 3185.49 lei
- 5% Preț: 1418.27 lei
- 5% Preț: 784.64 lei
- 5% Preț: 714.63 lei
- 5% Preț: 370.74 lei
- 5% Preț: 376.22 lei
- 5% Preț: 660.85 lei
- 5% Preț: 368.37 lei
Preț: 1419.94 lei
Preț vechi: 1494.66 lei
-5% Nou
Puncte Express: 2130
Preț estimativ în valută:
271.77€ • 282.66$ • 227.75£
271.77€ • 282.66$ • 227.75£
Carte tipărită la comandă
Livrare economică 13-27 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461358275
ISBN-10: 1461358272
Pagini: 484
Ilustrații: XXV, 453 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
ISBN-10: 1461358272
Pagini: 484
Ilustrații: XXV, 453 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Subcellular Basis of Heart Failure.- 1. Tumor Necrosis Factor-Alpha in Chronic Heart Failure.- 2. Myocardial Ribonuclease Activity in Heart Failure.- 3. ?-Adrenergic Receptor Mechanisms in Heart Failure.- 4. Vascular ?-Adrenergic Function in Congestive heart Failure.- 5. Altered Myocardial Neurotransmitter and 1,2-Diacylglycerol Concentrations in Right Ventricular Hypertrophy and Failure in Rats.- 6. Metabolic Changes in Nonischemic Myocardium During Pump Failure.- 7. Cardiac Extracellular Matrix and its Role in the Development of Heart Failure.- 8. SHHF/Mcc-fa3cp— Rat Model: A Genetic Model of Congestive Heart Failure.- 9. Left Ventricular Mass and Diastolic Function in Young Individuals with a first elevated “Casual” Blood Pressure.- 10. Factors Responsible for Left Ventricular Underfilling in Pure Mitral Stenosis.- 11. Improved Preservation of Myocardial ultrastructure in Perfusion-Fixed Human Heart Expiants.- 12. Involvement of Leukotoxin in the Pathogenesis of Patients with Extensive Burns.- 13. Differential Regulation of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase Isozymes.- II. Pathophysiologic Aspects of Cardiomyopathies.- 14. Adriamycin Cardiomyopathy and its Prevention in an Animal Model.- 15. Alterations in Sarcolemmal Phospholipid Base Exchange Enzymatic Activities in Diabetic Cardiomyopathy.- 16. Myocardial Lipid Peroxidation and Diabetes.- 17. Molecular Biologic Changes of Adenine Nucleotide Translocator in J-2-N Cardiomyopathic Hamsters.- 18. Renin-Angiotensin System and the Congenital Cardiomyopathic Hamster.- 19. Dietary Mercury Induces Congestive Cardiomyopathy in the Arctic.- 20. Peripheral Resistance to Atrial Natriuretic Peptide in Patients with Idiopathic Dilated.- 21. Effect of Ethanol on Allylamine-Induced SubendocardialFibrosis.- 22. Nitric Oxide: Friend and Foe in Myocardial Ischemia and Reperfusion.- 23. Role of Leukocytes and Subcellular Abnormalities in Diastolic Dysfunction During Ischemia-Reperfusion.- 24. Calcium Channel Blockade Ameliorates Cardiac Dysfunction and Failure in Ischemic Cardiomyopathy.- 25. Alterations in Autonomic Nervous System and Heart Mitochondrial Function in Rats Treated with Cyclophosphamide.- III. Treatment of Heart Failure.- 26. Combined Aerobic and Strength Training in Congestive Heart Failure Patients: Pilot Project on Safety and Feasibility.- 27. Factors Relating to 6 Minute Walk Performance in Heart Failure Patients.- 28. Dynamic Cardiomyoplasty: Management of Heart Failure Using Autologous Skeletal Muscle.- 29. Cardiac Cell Transplantation.- 30. Effects of Catalase on Volume-Overload Heart Failure.- 31. Major Determinants of Survival and Nonsurvival of Intra-aortic balloon Pumping.- 32. End-Stage Ischemic Heart Disease: Effects of Complete Myocardial Revascularization and Left Ventricular Patch Repair Following Scar Resection 369.- 33. Acute Enoximone Effect on Systemic Hemodynamics, Renal Function, and Hormonal Activation in Patients with Heart Failure.- 34. Angiotensin II Receptor Antagonist, E-4177, Inhibits Progression of Reactive Cardiac Hypertrophy Associated with Myocardial Infarction in Rats.- 35. Effects of Catecholamine and Amrinone on the Metabolism of Noninfarcted Myocardium in Cardiogenic Shock.- 36. Effects of Angiotensin Converting Enzyme Inhibitors on Acute Heart Failure Induced in the Anesthetized Dog with Microsphere Injection.- 37. Recruitment of Ventricular Function with Adjunctive Nitrate Therapy After Late Reperfusion.- 38. Neuromuscular Assessment of Heart Failure Patients.